-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CyYayXgMrSSzui8hIc4XM5pVl+XK4OQtD+Dig26ym/tVykdw0xoljXjT7aa2HsdV BfdWiFUHNQqFz8cvyOBPmQ== 0001181431-06-006516.txt : 20060130 0001181431-06-006516.hdr.sgml : 20060130 20060130180147 ACCESSION NUMBER: 0001181431-06-006516 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051231 FILED AS OF DATE: 20060130 DATE AS OF CHANGE: 20060130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORLIN STEVE CENTRAL INDEX KEY: 0001033742 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20837 FILM NUMBER: 06563388 BUSINESS ADDRESS: BUSINESS PHONE: 3012179858 MAIL ADDRESS: STREET 1: 150 GULF SHORE DRIVE STREET 2: UNIT 601 CITY: DESTIN STATE: FL ZIP: 32541 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 5 1 rrd102963.xml DARA CHANGE IN TYPE OF OWNERSHIP X0202 5 2005-12-31 1 0 0 0001011835 MEDIVATION, INC. MDVN.OB 0001033742 GORLIN STEVE C/O MEDIVATION, INC. 501 SECOND STREET, SUITE 211 SAN FRANCISCO CA 94107 1 0 1 0 Common Stock 233780 I By Trust Common Stock 759093 I See Footnote Shares represent a pro rata distribution from Dara BioSciences, Inc., of which the reporting person is Chairman of the Board and a principal stockholder. As such, in prior reports the reporting person reported indirect beneficial ownership of an aggregate of 2,657,317 shares of Medivation, Inc. common stock held by Dara BioSciences, Inc. Shares held by the Steve Gorlin Revocable Trust u/i/d May19, 1998, of which the reporting person is the trustee and beneficiary. Represents post-distribution net securities held by Dara BioSciences, Inc., of which the reporting person is Chairman of the Board of Directors and principal stockholder. C. Patrick Machado, Attorney-In-Fact for Steve Gorlin 2006-01-30 -----END PRIVACY-ENHANCED MESSAGE-----